Human papillomavirus (HPV) infection in heterosexual South African men attending sexual health services: Associations between HPV and HIV serostatus

Sexually Transmitted Infections

Volumn 86, Issue 3, 2010, Pages 175-180

  Müller, Etienne E ^a   Chirwa, Tobias F ^b   Lewis, David A ^a,c,d  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; GENOTYPE; HEALTH CENTER; HEALTH SERVICE; HETEROSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; SEROLOGY; SEXUAL BEHAVIOR; SOUTH AFRICA; URETHRA DISEASE; WART VIRUS;

ADULT; AGED; ANUS DISEASES; CIRCUMCISION, MALE; CONDYLOMATA ACUMINATA; DNA, VIRAL; GENOTYPE; HETEROSEXUALITY; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PREVALENCE; SOUTH AFRICA; URETHRAL DISEASES; YOUNG ADULT;

EID: 77953805518     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2009.037598     Document Type: Article

References (28)

1. Palefsky JM, Barrasso R. HPV infection and disease in men. Obstet Gynecol Clin North Am 1996;23:895-916.
2. Giulano AR, Tortolero-Luna G, Ferrer E, et al. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 2008;26S:K17-28.
3. Svare EI, Kjaer SK, Worm AM, et al. Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect 2002;78:215-18.
4. Dunne EF, Nielson CM, Stone KM, et al. Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis 2006;194:1044-57.
5. Chan PK, Luk AC, Luk TN, et al. Distribution of human papillomavirus types in anogenital warts of men. J Clin Virol 2009;44:111-14.
6. Kubba T. Human papillomavirus vaccination in the United Kingdom: what about boys? Reprod Health Matters 2008;32:97-103.
7. Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008;113(10 Suppl):3036-46.
8. Gerend MA, Barley J. Human papillomavirus vaccine acceptability among young adult men. Sex Transm Dis 2009;36:58-62.
9. Goldstein MA. Human papillomavirus vaccine in males. N Engl J Med 2008;359:863-4.
10. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Summary report on HPV and cervical cancer statistics in South Africa, 2007. http://www.who.int/hpvcentre (accessed 26 Aug 2009).
11. Geipert N. Vaccinating men for HPV: new strategy for preventing cervical cancer in women? J Natl Cancer Inst 2005;97:630-1.
12. Barr E, Tamms G. Quadrivalent human papillomavirus vaccine. Clin Infect Dis 2007;45:609-17.
13. Palefski J. Biology of HPV in HIV infection. Adv Dent Res 2006;19:99-105.
14. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000;92:1500-10.
15. Dolei A, Curreli S, Marongiu P, et al. Human immunodeficiency virus infection in vitro activates naturally integrated human papillomavirus type 18 and includes synthesis of the L1 capsid protein. J Gen Virol 1999;80:2937-44.
16. Clarke B, Chetty R. Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer. Mol Pathol 2002;55:19-24.
17. Gardasil (quadrivalent human papillomavirus [types 6, 11, 16, 18] recombinant vaccine) [product monograph]. Kirkland (QC): Merck Frosst Canada Ltd, 2006.
18. Hernandez BY, McDuffie K, Goodman MT, et al. Comparison of physician- and self-collected genital specimens for detection of human papillomavirus in men. J Clin Microbiol 2006;44:513-17.
19. Weaver BA, Feng Q, Holmes KK, et al. Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis 2004;189:677-85.
20. Aguilar LV, Lazcano-Ponce E, Vaccarella S, et al. Human papllomavirus in men: comparison of different genital sites. Sex Transm Infect 2006;82:31-3.
21. Giuliano AR, Nielson CM, Flores R. The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: The HPV detection in men study. J Infect Dis 2007;196:1146-52.
22. Nielson CM, Flores R, Harris RB, et al. Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev 2007;16:1107-14.
23. Smith JS, Moses S, Hudgens M, et al. Human papillomavirus detection by penile site in young men from Kenya. Sex Transm Dis 2007;34:928-34.
24. Leon R. Ladies first. Should boys be vaccinated against HPV? Can Fam Physician 2008;54:967-8.
25. Harries J, Moodley J, Barone MA, et al. Preparing for HPV vaccination in South Africa: Key challenges and opinions. Vaccine 2009;27:38-44.
26. Smits PHM, Bakker R, Jong E, et al. High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men. J Clin Microbiol 2005;43:5936-9.
27. Le Poole C, Denman CJ, Arbiser JL. Immunosuppression may be present within condyloma acuminata. J Am Acad Dermatol 2008;59:967-74.
28. Auvert B, Sobngwi-Tambekou J, Cutler E, et al. Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: Results of a randomized controlled trial conducted in Orange Farm, South Africa. J Infect Dis 2009;199:14-19.